Benzonatate and Isosorbide dinitrate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Benzonatate (benzonatate) and Isosorbide dinitrate (isosorbide dinitrate). Common drug interactions include chest discomfort among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Isosorbide dinitrate. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.
What is Benzonatate?
Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.
What is Isosorbide dinitrate?
Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.
75 people who take Benzonatate and Isosorbide dinitrate together, and have interactions are studied.

What are the common drug interactions of Benzonatate and Isosorbide Dinitrate, by gender? *:
female:
- Chest discomfort
- Chest pain
- Contusion (a type of hematoma of tissue in which capillaries)
- Joint range of motion decreased (disease of joint movement)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Spinal osteoarthritis (joint cartilage loss in spine)
- Urinary tract infection
- Abnormal faeces (abnormal stool)
- Acute respiratory failure
- Anxiety
male:
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Chest pain
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Fatigue (feeling of tiredness)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Insomnia (sleeplessness)
- Pain in extremity
What are the common drug interactions of Benzonatate and Isosorbide Dinitrate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Dizziness
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Vision blurred
50-59:
- Nephrogenic anaemia (anaemia due to kidney disease)
- Blood cholesterol increased
- Blood creatinine increased
- Blood triglycerides increased
- Decreased activity
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Pancreatitis (inflammation of pancreas)
- Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
60+:
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Contusion (a type of hematoma of tissue in which capillaries)
- Nausea (feeling of having an urge to vomit)
- Oedema peripheral (superficial swelling)
- Pulmonary oedema (fluid accumulation in the lungs)
- Spinal osteoarthritis (joint cartilage loss in spine)
- Abnormal faeces (abnormal stool)
- Aortic arteriosclerosis (hardening of the aortic arteries)
- Arterial fibrosis (common cardiac arrhythmia)
What are the existing conditions these people have? *
- High Blood Pressure: 29 people, 38.67%
- Insomnia (sleeplessness): 26 people, 34.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 25.33%
- High Blood Cholesterol: 17 people, 22.67%
- Constipation: 15 people, 20.00%
- Depression: 13 people, 17.33%
- Diabetes: 12 people, 16.00%
- Pain: 12 people, 16.00%
- Fever: 11 people, 14.67%
- Type 2 Diabetes: 10 people, 13.33%
* Approximation only. Some reports may have incomplete information.
Do you take Benzonatate and Isosorbide dinitrate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Benzonatate (17,274 reports)
- Isosorbide dinitrate (13,180 reports)
Browse all drug interactions of Benzonatate and Isosorbide dinitrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Benzonatate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Isosorbide dinitrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Benzonatate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Isosorbide dinitrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on benzonatate and isosorbide dinitrate (the active ingredients of Benzonatate and Isosorbide dinitrate, respectively), and Benzonatate and Isosorbide dinitrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fever and Dizziness - 9 seconds ago
- Drug interactions of Cosopt and Temazepam - 20 seconds ago
- Could Succinylcholine Chloride cause Disseminated Intravascular Coagulation? - 31 seconds ago
- Enlarged Prostate and Suicidal Ideation - 33 seconds ago
- Drug interactions of Polysporin and Colace - 44 seconds ago
- Could Wellbutrin cause Sjogren Syndrome? - 46 seconds ago
- Drug interactions of Repatha and Celecoxib - 51 seconds ago
- Could Prelone cause Joint Pain? - 56 seconds ago
- Drug interactions of Diastat Acudial and Onfi - a minute ago
- Could Ozempic cause Injection Site Reaction? - a minute ago